Loading...

Zomedica Corp.

ZOMAMEX
Healthcare
Drug Manufacturers - Specialty & Generic
$0.10
$-0.00(-0.21%)

Zomedica Corp. (ZOM) Stock Overview

Explore Zomedica Corp.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 65.2/100

Key Financials

Market Cap95.3M
P/E Ratio-0.94
EPS (TTM)$-0.06
ROE-0.55%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 Months$0.10
1 Year Target$0.03

ZOM Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Zomedica Corp. (ZOM) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.03.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.94 and a market capitalization of 95.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;